Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
134,990,733
-
Total 13F shares
-
6,240,225
-
Share change
-
-1,109,021
-
Total reported value
-
$10,171,898
-
Price per share
-
$1.63
-
Number of holders
-
26
-
Value change
-
-$1,798,653
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2025
As of 31 Dec 2025,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,240,225 shares.
The largest 10 holders included
VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Assenagon Asset Management S.A., UBS Group AG, GOLDMAN SACHS GROUP INC, GSA CAPITAL PARTNERS LLP, Bank of New York Mellon Corp, Total Clarity Wealth Management, Inc., and Benin Management CORP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.